Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma.

IF 2.3 2区 医学 Q2 OPHTHALMOLOGY
Megan S Steinkerchner, Anne M Lane, Evangelos S Gragoudas, Ivana K Kim, Frances Wu
{"title":"Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma.","authors":"Megan S Steinkerchner, Anne M Lane, Evangelos S Gragoudas, Ivana K Kim, Frances Wu","doi":"10.1097/IAE.0000000000004462","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the outcomes of persistent large exudative retinal detachments (ERD) following proton beam irradiation (PBI) for choroidal melanoma.</p><p><strong>Methods: </strong>A retrospective study evaluated patients with a diagnosis of ERD in the setting of choroidal melanoma treated with PBI at a single academic tertiary center. Inclusion criteria were the presence of an ERD for at least 3 clock hours at the time of melanoma diagnosis. Data collected included tumor features, management, and visual and anatomic outcomes.</p><p><strong>Results: </strong>The study comprised 50 eyes of 50 patients with a median age of 51.7 years (range 19.3 - 78.5 years) and a median follow-up of 35.1 months (range 6.6 - 247.9 months). Thirty-five patients were treated with conservative management, which included observation or intraocular steroids, and 15 patients underwent surgical management with pars plana vitrectomy, drainage of subretinal fluid, endolaser, and silicone oil placement for persistent ERD at a median duration of 7.5 months (range 1.3-117.6 months) following PBI. The study found no difference in outcomes of final visual acuity, radiation retinopathy, neovascular glaucoma, and enucleation between conservative and surgical management. Refractory ERD was found to be a significant risk factor for the development of neovascular glaucoma.</p><p><strong>Conclusion: </strong>Choroidal melanoma with a large ERD can be successfully treated with conservative or surgical management after proton beam radiation therapy.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004462","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To assess the outcomes of persistent large exudative retinal detachments (ERD) following proton beam irradiation (PBI) for choroidal melanoma.

Methods: A retrospective study evaluated patients with a diagnosis of ERD in the setting of choroidal melanoma treated with PBI at a single academic tertiary center. Inclusion criteria were the presence of an ERD for at least 3 clock hours at the time of melanoma diagnosis. Data collected included tumor features, management, and visual and anatomic outcomes.

Results: The study comprised 50 eyes of 50 patients with a median age of 51.7 years (range 19.3 - 78.5 years) and a median follow-up of 35.1 months (range 6.6 - 247.9 months). Thirty-five patients were treated with conservative management, which included observation or intraocular steroids, and 15 patients underwent surgical management with pars plana vitrectomy, drainage of subretinal fluid, endolaser, and silicone oil placement for persistent ERD at a median duration of 7.5 months (range 1.3-117.6 months) following PBI. The study found no difference in outcomes of final visual acuity, radiation retinopathy, neovascular glaucoma, and enucleation between conservative and surgical management. Refractory ERD was found to be a significant risk factor for the development of neovascular glaucoma.

Conclusion: Choroidal melanoma with a large ERD can be successfully treated with conservative or surgical management after proton beam radiation therapy.

目的:评估脉络膜黑色素瘤质子束照射(PBI)后持续性大面积渗出性视网膜脱离(ERD)的治疗效果:一项回顾性研究评估了在一家学术性三级中心接受质子束照射治疗的脉络膜黑色素瘤患者的ERD诊断情况。纳入标准为黑色素瘤确诊时ERD存在至少3个小时。收集的数据包括肿瘤特征、管理、视觉和解剖结果:研究包括 50 位患者的 50 只眼睛,中位年龄为 51.7 岁(19.3 - 78.5 岁),中位随访时间为 35.1 个月(6.6 - 247.9 个月)。35 名患者接受了保守治疗,包括观察或眼内类固醇治疗,15 名患者接受了手术治疗,包括玻璃体旁切除术、视网膜下积液引流术、内激光术和硅油置入术,以治疗 PBI 后持续性 ERD,中位持续时间为 7.5 个月(1.3-117.6 个月)。研究发现,保守治疗和手术治疗在最终视力、放射性视网膜病变、新生血管性青光眼和眼球摘除术的结果上没有差异。研究发现,难治性ERD是发生新生血管性青光眼的重要风险因素:结论:质子束放射治疗后,伴有大面积ERD的脉络膜黑色素瘤可通过保守或手术治疗获得成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
9.10%
发文量
554
审稿时长
3-6 weeks
期刊介绍: ​RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信